Practice Management

P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call

Retrieved on: 
Thursday, May 2, 2024
Managed Care, Health Insurance, Health, Practice Management, P3, Webcast

The conference call will also be webcast live in the "Events & Presentations" section of the Investor page of the P3 website ( ir.p3hp.org ).

Key Points: 
  • The conference call will also be webcast live in the "Events & Presentations" section of the Investor page of the P3 website ( ir.p3hp.org ).
  • The Company’s press release will be available on the Investor page of P3’s website in advance of the conference call.
  • An archived recording of the webcast will be available on the Investor page of P3’s website for a period of 90 days following the conference call.

IQVIA Reports First-Quarter 2024 Results

Retrieved on: 
Thursday, May 2, 2024
Technology, Managed Care, General Health, Hospitals, Science, Clinical Trials, Health, Health Technology, Other Science, Research, Other Technology, Software, Other Health, Networks, Mobile, Wireless, Data Management, Practice Management, COVID, Webcast, Growth, Free cash flow, DS, TAS, EPS, Adjustment, ID, RFP, GAAP, IQV, Cryptocurrency

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.

Key Points: 
  • IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.
  • As of March 31, 2024, R&DS contracted backlog, including reimbursed expenses, was $30.1 billion, growing 7.9 percent year-over-year and 8.3 percent at constant currency.
  • “The IQVIA team executed well in the first quarter, including strong bookings and robust free cash flow generation,” stated Ari Bousbib, chairman and CEO of IQVIA.
  • IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its first-quarter 2024 results and its second-quarter and full-year 2024 guidance.

Spok Reports First Quarter 2024 Results

Retrieved on: 
Wednesday, May 1, 2024
Technology, Nursing, Hospitals, Other Technology, Health Technology, Software, Practice Management, Health, Data Management, Investment, ARPU, Communication, Research, History, SPOK, Spok, Wireless, Growth, Video game

Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the first quarter ended March 31, 2024.

Key Points: 
  • Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the first quarter ended March 31, 2024.
  • In fact, the $7.9 million of software operations bookings in the first quarter was the second highest first quarter performance in our history.
  • "We were very pleased with our performance in the first quarter and believe that it provides a solid springboard for 2024.
  • Of course, we will continue to update you on our outlook each quarter when we report our results," concluded Kelly.

Tenet to Participate in BofA Securities 2024 Health Care Conference

Retrieved on: 
Wednesday, May 1, 2024
General Health, Surgery, Hospitals, Health, Practice Management, Bank of America, BofA Securities, Tenet Healthcare, Conference, THC

Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024, beginning at 12:20 p.m. Eastern time.

Key Points: 
  • Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024, beginning at 12:20 p.m. Eastern time.
  • A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet’s website at www.tenethealth.com/investors .
  • The replay will be available for 30 days.

Phreesia’s Alicia Cowley and Natasha Vega Named to MM+M’s ‘Women to Watch’ for 2024

Retrieved on: 
Wednesday, May 1, 2024
Technology, Women, Human Resources, Health Technology, Professional Services, Software, Practice Management, Other Health, Consumer, Health, OMD, Health equity, HCP, Boehringer Ingelheim, Woman, Communication, MD, Patient, MBA, Creativity, Nursing

Phreesia is pleased to announce that the healthcare marketing industry trade publication MM+M has named Alicia Cowley, MD, MBA, Director of Clinical Content, and Natasha Vega, MS, Senior Client Experience Manager, to its Women to Watch class of 2024.

Key Points: 
  • Phreesia is pleased to announce that the healthcare marketing industry trade publication MM+M has named Alicia Cowley, MD, MBA, Director of Clinical Content, and Natasha Vega, MS, Senior Client Experience Manager, to its Women to Watch class of 2024.
  • Cowley and Vega were two of just 23 women to receive the “Women to Watch” distinction this year.
  • Cowley and Vega both fill instrumental roles in supporting Phreesia’s vision of helping every patient take an active role in their care.
  • "Helping patients become advocates in their own healthcare journey is one of the things I love most about my job,” said Vega.

Urological Services Has Joined Solaris Health

Retrieved on: 
Wednesday, May 1, 2024
Hospitals, General Health, Health, Practice Management, Holland & Knight, Patient, Lee Equity Partners, Trust

Solaris Health Holdings announced today that Urological Services, of Flint, MI, has joined as an affiliate.

Key Points: 
  • Solaris Health Holdings announced today that Urological Services, of Flint, MI, has joined as an affiliate.
  • Urological Services brings to Solaris the skills and talents of 10 providers who care for over 18,000 unique patients each year.
  • “Partnering with Solaris will expand our capacity to offer a full suite of urologic services, while preserving our autonomy,” said Dr. Jason Evans, Market President at Urological Services.
  • Holland & Knight LLP served as legal counsel to Solaris on the Urological Services deal.

Connecticut Magazine Honors 39 Physicians from Summit Health and Starling Physicians

Retrieved on: 
Wednesday, May 1, 2024
General Health, Health, Practice Management, Other Health, Connecticut Magazine, Physician, Summit Health, MD, Patient, Nursing

Thirty-nine physicians from Summit Health and Starling Physicians were named as 2024 “Top Doctors” by Connecticut Magazine.

Key Points: 
  • Thirty-nine physicians from Summit Health and Starling Physicians were named as 2024 “Top Doctors” by Connecticut Magazine.
  • The physicians are nominated by their colleagues to earn Top Doctor recognition through the national Castle Connolly’s annual peer doctor-survey.
  • Summit Health also has one doctor listed as a Rising Star in the May issue.
  • “At Summit Health and Starling Physicians, our team of physicians works tirelessly to provide exceptional care for patients throughout their lifetime,” says Adam Barrison, MD, Chief Physician Executive at Summit Health.

Houlihan Lokey Healthcare Group Adds Experienced Hire

Retrieved on: 
Wednesday, May 1, 2024
Professional Services, Health, Hospitals, Practice Management, Other Health, Pharmaceutical, Banking, Capital market, Houlihan Lokey, Health care, Moelis & Company, Pharmaceutical industry

Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Erik Kistler has joined the firm’s Healthcare Group as a Managing Director.

Key Points: 
  • Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Erik Kistler has joined the firm’s Healthcare Group as a Managing Director.
  • Based in New York, Mr. Kistler will cover selected areas within healthcare retail multi-site, physician practices, and pharma services.
  • Mr. Kistler joins the firm after spending two years as an Executive Director at Moelis & Company.
  • “We are thrilled to have Erik joining our leading Healthcare team,” said Mike Pisani, Managing Director and Co-Head of U.S. Healthcare at Houlihan Lokey.

Surescripts Launches Third Season of Its Award-Winning Podcast There’s A Better Way

Retrieved on: 
Wednesday, May 1, 2024
Public Policy, Government, Practice Management, Pharmaceutical, Managed Care, General Health, Health, Healthcare Reform, Health Technology, FDA, Professional, Organization, Mayo Clinic, HHS, Human services, Marketing, EHR, Health care, Customer experience, Patient safety, Patient, Surescripts, Gold, American Telemedicine Association, MPP, Season, Better Way, EHNAC, Pharmacist, Management

Surescripts®, the nation’s leading health information network, launched the third season of its award-winning podcast, There’s a Better Way: Smart Talk on Healthcare and Technology.

Key Points: 
  • Surescripts®, the nation’s leading health information network, launched the third season of its award-winning podcast, There’s a Better Way: Smart Talk on Healthcare and Technology.
  • Listen to There’s a Better Way: Season 3 trailer .
  • Surescripts introduced There’s a Better Way: Smart Talk on Healthcare and Technology in July 2022.
  • Both season one and season two were recognized by the Association of Marketing and Communication Professionals, receiving the 2022 Gold MarCom Award and the 2023 Platinum MarCom Award, respectively.

Ventegra Announces the Successful Implementation of the New Ventegra Specialty Inclusion (VSI) Program

Retrieved on: 
Wednesday, May 1, 2024
Technology, Consulting, Professional Services, Health Insurance, Software, Practice Management, Managed Care, Pharmaceutical, Health, Data Management, Pharmacy, Probability, Safety, Explanation, Plasma protein binding, MBM, Pharming, MBA, Pharmacist, VSI

The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.

Key Points: 
  • The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.
  • Mark Shinmoto, Pharm.D., Chief Pharmacy Officer, says, “The Ventegra Specialty Inclusion (VSI) program’s capability is a vital and important new tool in Ventegra’s ability to appropriately manage the utilization of the plethora of drugs being brought to market.
  • Robert T. Taketomo, Pharm.D., MBA, President/CEO, explains, “The Ventegra Specialty Inclusion program reflects the clinical focus of Ventegra and our deep commitment to member care and managed care principles.
  • Unlike most traditional pharmacy benefit managers, Ventegra does not have any fiduciary commitment to shareholders and exists to serve and benefit its community.